Forma Therapeutics gets European orphan drug status for FT-4202 to treat sickle cell disease

Forma Therapeutics gets European orphan drug status for FT-4202 to treat sickle cell disease

Submitted by admin on November 12, 2020 - 10:40am
Source: 
Pharmaceutical Business Review
News Tags: 
Forma Therapeutics
orphan drugs
Europe
FT-4202
sickle cell disease
Headline: 
Forma Therapeutics gets European orphan drug status for FT-4202 to treat sickle cell disease
snippet: 

Forma Therapeutics has secured orphan drug status from the European Commission (EC) for its FT-4202 to treat sickle cell disease (SCD).

Do Not Allow Advertisers to Use My Personal information